Cardinal Health (NYSE:CAH) Releases FY 2026 Earnings Guidance

Key Points

• Cardinal Health has provided earnings per share (EPS) guidance of 9.300-9.500 for FY 2026, significantly higher than the consensus estimate of 8.193.
• The company's stock showed a 0.4% increase on the day of the earnings guidance release, with shares opening at $158.07.
• Wall Street analysts maintain a consensus rating of "Moderate Buy" for Cardinal Health, with twelve analysts assigning a buy rating and a consensus price target of $158.07.

Cardinal Health (NYSE:CAH - Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 9.300-9.500 for the period, compared to the consensus estimate of 8.193. The company issued revenue guidance of -.

Cardinal Health Stock Up 0.4%

Shares of NYSE CAH opened at $158.07 on Tuesday. Cardinal Health has a 52 week low of $100.07 and a 52 week high of $168.44. The business has a 50-day simple moving average of $160.10 and a two-hundred day simple moving average of $144.16. The company has a market cap of $37.73 billion, a P/E ratio of 24.66, a P/E/G ratio of 1.56 and a beta of 0.67.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of research analyst reports. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a research report on Tuesday. Morgan Stanley reiterated an "overweight" rating on shares of Cardinal Health in a research report on Tuesday. Wall Street Zen downgraded Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research report on Tuesday. Finally, Evercore ISI reiterated an "outperform" rating and set a $180.00 price target (up previously from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Three investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Cardinal Health has a consensus rating of "Moderate Buy" and a consensus price target of $158.07.

Hedge Funds Weigh In On Cardinal Health

An institutional investor recently raised its position in Cardinal Health stock. Jones Financial Companies Lllp boosted its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 198.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,112 shares of the company's stock after purchasing an additional 14,034 shares during the period. Jones Financial Companies Lllp's holdings in Cardinal Health were worth $27,000 at the end of the most recent reporting period. 87.17% of the stock is owned by institutional investors.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.